2009: Latest drug treatments in metastasized Kidney Cancer (mRCC)
Currently Available Treatment Options:
- Votrient (pazopanib) (2009) New!!!
….. See Phase III clinical trial below
….. Cure Today
….. Doubts are expressed over drugs safety
- Afinitor (everolimus) (2009)
….. Side Effects
….. Consumer Drug Information
….. Professional Information
- Avastin (bevacizumab) with Interferon Alpha-2a (IFN) (2009)
….. Side Effects
….. Consumer Drug Information
….. Professional Information
- Interferon Alpha-2a (1980’s)
….. Side Effects
….. Consumer Drug Information
….. Professional Information
- Nexavar (sorafenib) (2005)
….. Side Effects
….. Consumer Drug Information
….. Professional Information
- Proleukin, Interleukin-2 (IL-2, or mIL-2) (1992)
….. Proleukin Side Effects
….. Proleukin Drug Information
….. Proleukin Professional Information
- Sutent (sunitinib) (2006)
….. Side Effects
….. Consumer Drug Information
….. Professional Information
- Torisel (temsirolimus) (2007)
….. Side Effects
….. Consumer Drug Information
….. Professional Information
Clinical Trials, Phase III:
- Pazopanib (1) (2) (3) (4) Now approved!!! See above
Clinical Trials, Phase II: - Aflibercept (1)
- Axitinib (1) (2) (3)
- Desatinib
- Ixabepilone (1)
- Vandetanib (1)
- Vorinostat (1) (2)
Clinical Trials, Phase I:
- Vatalanib (1)
- Yttrium-90 conjugated chimeric G250 (90Y-cG250)
Resource: Cancer Support Forum Information sorted out by Darryl
The development of more effective cancer treatments requires that new and innovative therapies be evaluated with cancer patients. Clinical trials are studies that evaluate the effectiveness of new drugs or treatment strategies. Future progress in the treatment of renal cell cancer will result from the continued evaluation of new treatments in clinical trials.
Patients may gain access to better treatments by participating in a clinical trial. Participation in a clinical trial also contributes to the cancer community’s understanding of optimal cancer care and may lead to better standard treatments. Patients who are interested in participating in a clinical trial should discuss the risks and benefits of clinical trials with their physician.
